Carterra Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 81

Employees

  • Latest Deal Type
  • General Corporate Purpose

  • Investors
  • 8

Carterra General Information

Description

Operator of a biosensor platform intended to accelerate the discovery of novel therapeutic candidates. The company's monoclonal antibody (mAb) characterization platform combines patented microfluidic technology with real-time high-throughput surface plasmon resonance (HT-SPR), kinetic and epitope analysis, and visualization software, enabling pharmaceutical and biotechnology clients to rapidly and comprehensively screen antibodies and identify potential novel therapeutic candidates.

Contact Information

Formerly Known As
Wasatch Microfluidics Management Compensation Issuance, Wasatch Microfluidics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 825 North 300 West
  • Suite C309
  • Salt Lake City, UT 84103
  • United States
+1 (844)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 825 North 300 West
  • Suite C309
  • Salt Lake City, UT 84103
  • United States
+1 (844)

Carterra Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carterra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. General Corporate Purpose 01-Apr-2026 Completed Generating Revenue
19. Later Stage VC 23-Apr-2024 Completed Generating Revenue
18. Debt Refinancing 13-Apr-2023 Completed Generating Revenue
17. Later Stage VC 13-May-2021 Completed Generating Revenue
16. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
15. Later Stage VC (Series G) 22-Dec-2020 Completed Generating Revenue
14. Debt - PPP 27-Apr-2020 Completed Generating Revenue
13. Later Stage VC (Series F) 19-Dec-2019 Completed Generating Revenue
12. Later Stage VC (Series E) 17-Jan-2018 $10M $23.5M Completed Generating Revenue
11. Later Stage VC (Series D) 17-Aug-2016 $10.3M $13.5M Completed Generating Revenue
To view Carterra’s complete valuation and funding history, request access »

Carterra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series G
Series F
Series E
Series D
Series C
Series B 887,170 $0.001000 $1.13 $1.13 1x $1.13 3.52%
Series A 344,923 $0.001000 $0.86 $0.86 1x $0.86 1.37%
To view Carterra’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Carterra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biosensor platform intended to accelerate the discovery of novel therapeutic candidates. The company's mon
Discovery Tools (Healthcare)
Salt Lake City, UT
81 As of 2026

Munich, Germany
 

Munich, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Carterra Competitors (4)

One of Carterra’s 4 competitors is Nanion Technologies, a Accelerator/Incubator Backed company based in Munich, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nanion Technologies Accelerator/Incubator Backed Munich, Germany
NanoTemper Technologies Corporation Munich, Germany
SPT Labtech Private Equity-Backed Melbourn, United Kingdom
Proteros biostructures Private Equity-Backed Martinsried, Germany
To view Carterra’s complete competitors history, request access »

Carterra Patents

Carterra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260016685-A1 Non-sequential scanning of substances Pending 05-Jul-2024
WO-2026011027-A2 Non-sequential scanning of substances Pending 05-Jul-2024
WO-2026011027-A3 Non-sequential scanning of substances Pending 05-Jul-2024
US-20250153170-A1 Fluid control adapters Pending 14-Nov-2023
EP-4649303-A1 Microfluidic flow cell arrays Pending 11-Jan-2023 B01L3/50273
To view Carterra’s complete patent history, request access »

Carterra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carterra Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Revvity Corporation Minority
Ballast Point Partners Growth/Expansion Minority
Shepherd Growth Partners Venture Capital Minority
Telegraph Hill Partners Venture Capital Minority
Frazier VC Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Carterra FAQs

  • When was Carterra founded?

    Carterra was founded in 2005.

  • Where is Carterra headquartered?

    Carterra is headquartered in Salt Lake City, UT.

  • What is the size of Carterra?

    Carterra has 81 total employees.

  • What industry is Carterra in?

    Carterra’s primary industry is Discovery Tools (Healthcare).

  • Is Carterra a private or public company?

    Carterra is a Private company.

  • What is Carterra’s current revenue?

    The current revenue for Carterra is .

  • How much funding has Carterra raised over time?

    Carterra has raised $42.6M.

  • Who are Carterra’s investors?

    Revvity, Ballast Point Partners, Shepherd Growth Partners, Telegraph Hill Partners, and Frazier VC are 5 of 8 investors who have invested in Carterra.

  • Who are Carterra’s competitors?

    Nanion Technologies, NanoTemper Technologies, SPT Labtech, and Proteros biostructures are competitors of Carterra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process